Angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to Kawasaki disease: a meta-analysis

被引:9
作者
Pan, Yan [1 ]
Lu, Hongzhu [1 ,2 ]
机构
[1] Yangtze Univ, Affiliated Hosp 1, Dept Pediat, Jingzhou, Hubei, Peoples R China
[2] Yangtze Univ, Med Coll, Jingzhou, Hubei, Peoples R China
关键词
ACE; I/D polymorphism; Kawasaki disease; DELETION POLYMORPHISM; GENE; SYSTEM;
D O I
10.4314/ahs.v17i4.6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The angiotensin-converting enzyme (ACE) I/D polymorphism has been reported to be associated with Kawasaki disease(KD), but studies to date present conflicting results. Objectives: The aim of this study is to derive a more precise estimation of the association between the ACE I/D polymorphism and KD risk. Methods: PubMed, EMBASE, CNKI and Wangfang databases were retrievaled to identify for relevant studies from inception to May 2017. Pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated using Stata 12.0 software. Results: A total of 6 case-control studies comprising 634 patients and 458 controls were included in the meta-analysis, and we found a significant association between the ACE I/D polymorphism and KD risk(D vs I: OR = 0.81, 95% CI = 0.31-2.11; DD vs II: OR = 1.03, 95% CI = 0.42-2.54; DI vs II: OR = 1.44, 95% CI = 1.09-1.90; dominant model: OR = 1.43, 95% CI = 1.11-1.85; recessive model: OR = 1.21, 95% CI = 0.44-3.29). When stratified by sample size>200, this polymorphism is associated with an increased the risk of KD. Conclusion: The I/D polymorphism in the ACE gene may be associated with susceptibility to KD.
引用
收藏
页码:991 / 999
页数:9
相关论文
共 21 条
[1]   The involvement of Fc gamma receptor gene polymorphisms in Kawasaki disease [J].
Biezeveld, M. ;
Geissler, J. ;
Merkus, M. ;
Kuipers, I. M. ;
Ottenkamp, J. ;
Kuijpers, T. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2007, 147 (01) :106-111
[2]  
Bryant J. W., 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P234
[3]   Kawasaki syndrome [J].
Burns, JC ;
Glodé, MP .
LANCET, 2004, 364 (9433) :533-544
[4]   Demystifying the ACE polymorphism: From genetics to biology [J].
Castellon, Raquel ;
Hamdi, Hamdi K. .
CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (12) :1191-1198
[5]   A Genetic Variant rs1801274 in FCGR2A as a Potential Risk Marker for Kawasaki Disease: A Case-Control Study and Meta-Analysis [J].
Duan, Jiayu ;
Lou, Jiao ;
Zhang, Qing ;
Ke, Juntao ;
Qi, Yanqi ;
Shen, Na ;
Zhu, Beibei ;
Zhong, Rong ;
Wang, Zhenling ;
Liu, Lifeng ;
Wu, Jing ;
Wang, Wei ;
Gong, Fangqi ;
Miao, Xiaoping .
PLOS ONE, 2014, 9 (08)
[6]   Meta-analysis: Principles and procedures [J].
Egger, M ;
Smith, GD ;
Phillips, AN .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7121) :1533-1537
[7]   Possible synergic effect of angiotensin-I converting enzyme gene insertion/deletion polymorphism and angiotensin-II type-1 receptor 1166A/C gene polymorphism on ischemic heart disease in patients with Kawasaki disease [J].
Fukazawa, R ;
Sonobe, T ;
Hamamoto, K ;
Hamaoka, K ;
Sakata, K ;
Asano, T ;
Imai, T ;
Kamisago, M ;
Ohkubo, T ;
Uchikoba, Y ;
Ikegami, E ;
Watanabe, M ;
Ogawa, S .
PEDIATRIC RESEARCH, 2004, 56 (04) :597-601
[8]   In vitro modulation of a resistance artery diameter by the tissue renin-angiotensin system of a large donor artery [J].
Henrion, D ;
Benessiano, J ;
Levy, BI .
CIRCULATION RESEARCH, 1997, 80 (02) :189-195
[9]  
Kawasaki T, 1967, Arerugi, V16, P178
[10]   Angiotensin induces inflammatory activation of human vascular smooth muscle cells [J].
Kranzhöfer, R ;
Schmidt, J ;
Pfeiffer, CAH ;
Hagl, S ;
Libby, P ;
Kübler, W .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (07) :1623-1629